Hayat Pharmaceutical Industries Co (AMM:HPIC) E10: JOD0.38 (As of Mar. 2026)


AMM:HPIC Hayat Pharmaceutical Industries Co AMM:HPIC
79 GF Score
Price JOD3.13
GF Value JOD2.74
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Hayat Pharmaceutical Industries Co E10?

Hayat Pharmaceutical Industries Co AMM:HPIC +0.32% 79 E10 is JOD0.38 as of Mar. 2026. GuruFocus rates AMM:HPIC with a GF Score™ of 79/100 and a GF Value™ of JOD2.74 (Modestly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hayat Pharmaceutical Industries Co's adjusted earnings per share data for the three months ended in Mar. 2026 was JOD0.020. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is JOD0.38 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 0.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Hayat Pharmaceutical Industries Co was 0.90% per year. The lowest was 0.90% per year. And the median was 0.90% per year.

As of today (2026-06-28), Hayat Pharmaceutical Industries Co's current stock price is JOD3.13. Hayat Pharmaceutical Industries Co's E10 for the quarter that ended in Mar. 2026 was JOD0.38. Hayat Pharmaceutical Industries Co's Shiller PE Ratio of today is 8.24.

During the past 13 years, the highest Shiller PE Ratio of Hayat Pharmaceutical Industries Co was 11.29. The lowest was 6.49. And the median was 7.86.


Hayat Pharmaceutical Industries Co  (AMM:HPIC) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hayat Pharmaceutical Industries Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=3.13/0.38
=8.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Hayat Pharmaceutical Industries Co was 11.29. The lowest was 6.49. And the median was 7.86.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Hayat Pharmaceutical Industries Co E10 Related Terms


Hayat Pharmaceutical Industries Co E10 Historical Data

* Premium members only.

The historical data trend for Hayat Pharmaceutical Industries Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hayat Pharmaceutical Industries Co E10 Chart

Hayat Pharmaceutical Industries Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.37 0.37 0.38 0.38

Hayat Pharmaceutical Industries Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.39 0.38 0.38 0.38

AMM:HPIC vs ZTS, UTHR, VTRS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hayat Pharmaceutical Industries Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hayat Pharmaceutical Industries Co's Shiller PE Ratio falls into.


AMM:HPIC
79GF Score
Hayat Pharmaceutical Industries Co AMM:HPIC
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hayat Pharmaceutical Industries Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hayat Pharmaceutical Industries Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.02/330.2130*330.2130
=0.020

Current CPI (Mar. 2026) = 330.2130.

Hayat Pharmaceutical Industries Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.050 241.018 0.069
201609 0.090 241.428 0.123
201612 0.060 241.432 0.082
201703 0.043 243.801 0.058
201706 0.100 244.955 0.135
201709 0.090 246.819 0.120
201712 0.038 246.524 0.051
201803 0.086 249.554 0.114
201806 0.060 251.989 0.079
201809 0.060 252.439 0.078
201812 0.120 251.233 0.158
201903 0.080 254.202 0.104
201906 0.090 256.143 0.116
201909 0.080 256.759 0.103
201912 0.120 256.974 0.154
202003 0.150 258.115 0.192
202006 0.020 257.797 0.026
202009 0.090 260.280 0.114
202012 0.100 260.474 0.127
202103 0.210 264.877 0.262
202106 0.060 271.696 0.073
202109 0.110 274.310 0.132
202112 0.000 278.802 0.000
202203 0.030 287.504 0.034
202206 0.130 296.311 0.145
202209 0.130 296.808 0.145
202212 0.077 296.797 0.086
202303 0.020 301.836 0.022
202306 0.005 305.109 0.005
202309 0.070 307.789 0.075
202312 0.150 306.746 0.161
202403 0.030 312.332 0.032
202406 0.060 314.175 0.063
202409 0.030 315.301 0.031
202412 0.207 315.605 0.217
202503 0.050 319.799 0.052
202506 0.040 322.561 0.041
202509 0.060 324.800 0.061
202512 0.090 324.054 0.092
202603 0.020 330.213 0.020

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of JOD0.38 mean?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a E10 of JOD0.38 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Hayat Pharmaceutical Industries Co and its competitors.
Is Hayat Pharmaceutical Industries Co's E10 too high?
Hayat Pharmaceutical Industries Co's current E10 is JOD0.38. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's E10 compare to ZTS and UTHR?
Hayat Pharmaceutical Industries Co's E10 of JOD0.38 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Hayat Pharmaceutical Industries Co and its competitors. Hayat Pharmaceutical Industries Co's current E10 is JOD0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co (AMM:HPIC) is currently considered Modestly Overvalued. The stock's GF Value™ is JOD2.74, compared to a current price of JOD3.13 — trading 14.2% above its estimated fair value. The current E10 is JOD0.38. Hayat Pharmaceutical Industries Co's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current E10 is JOD0.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hayat Pharmaceutical Industries Co (AMM:HPIC) Overvalued in 2026?

Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co stock appears to be overvalued. The current stock price of JOD3.13 is trading 14.2% above its estimated GF Value™ of JOD2.74. GuruFocus considers Hayat Pharmaceutical Industries Co to be Modestly Overvalued.

Key valuation signals for AMM:HPIC:

  • E10: JOD0.38
  • GF Value™: JOD2.74 vs. price of JOD3.13 (14.2% above fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the AMM:HPIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hayat Pharmaceutical Industries Co Business Description

Address Mohammed Ali Alkurdi St. Al-Rajeeb Amman, 1564 Amman, Amman, JOR, 11118
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
79GF Score

Get the complete analysis for AMM:HPIC

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD3.13
Price
JOD2.74
GF Value